Short Term Monitoring

From dermoscopedia

5.00
(1 vote)

 Editor: Scott Menzies

Annotations
Description This page has not yet been summarized.
Author(s) Florentia Dimitriou · Scott Menzies
Responsible author Scott Menzies→ send e-mail
Status unknown
Status update June 14, 2017
Status by Ralph P. Braun


User=

every three months or less

  • Is performed for lesions, that because of history of appearance, cannot be deemed benign with absolute certainty at the initial examination.
  • It enables early detection of fearless melanomas while decreasing the need of excision of clinically suspicious benign lesions.
  • Any morphologic change seen at three months from baseline (short-term monitoring) requires excision.


Significant change Non-significant change
Any change other than non-significant changes Global change in pigmentation
Loss or appearance of milia-like cysts

Benign Lesions[edit]

  • Lesions remaining unchanged at 2-5-4.5 months are mostly confirmed benign on further follow-up.

Non-lentigo maligna type lesions[edit]

  • Lesions observed to change during the short-term interval of 2.5-4.5 months.

Lentigo maligna Lesions[edit]

  • The changes in lentigo maligna melanoma can develop very gradually and thus a longer follow-up interval is necessary to detect some of these melanomas. A monitored interval between 6-12 months is recommended.




References

  1. An Atlas of Dermoscopy, Second Edition. Marghoob A. et al. CRC Press; 2012.
  2. Altamura, D., Avramidis, M. & Menzies, S.W., 2008, Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy moni- toring for the diagnosis of melanoma. Arch Dermatol, 144, 502–6.
  3. Altamura, D., Zalaudek, I., Sera, F., et al., 2007, Dermoscopic changes in acral melanocytic nevi during digital follow-up. Arch Dermatol, 143, 1372–6.
  4. Argenziano, G., Zalaudek, I. & Ferrara, G., 2007, Fast-growing and slow-growing melanomas. Arch Dermatol, 143, 802–3; author reply 803–4.
  5. Banky, J.P., Kelly, J.W., English, D.R., Yeatman, J.M. & Dowling, J.P., 2005, Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol, 141, 998–1006.
  6. Bauer, J., Blum, A., Strohhäcker, U. & Garbe, C., 2005, Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy. Br J Dermatol, 152, 87–92.
  7. Dawid, M., Pehamberger, H., Wolff, K., Binder, M. & Kittler, H., 2002, Evaluation of the ability of patients to identify enlarging melanocytic nevi. Arch Dermatol, 138, 984–5. Fuller, S.R., Bowen, G.M., Tanner, B., Florell, S.R. & Grossman, D., 2007, Digital dermoscopic monitoring of atypical nevi in patients at risk for melanoma. Dermatol Surg, 33, 1198–206; discussion 1205–6.
  8. Haenssle, H.A., Krueger, U., Vente, C., et al., 2006, Results from an observational trial: digital epiluminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma. J Invest Dermatol, 126, 980–5.
  9. Kittler, H. & Binder, M., 2001, Risks and benefits of sequential imaging of melanocytic skin lesions in patients with multiple atypical nevi. Arch Dermatol, 137, 1590–5.
  10. Kittler, H. & Binder, M., 2002, Follow-up of melanocytic skin lesions with digital dermoscopy: risks and benefits. Archives of Dermatology, 138, 1379.
  11. Kittler, H., Pehamberger, H., Wolff, K. & Binder, M., 2000a, Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol, 43, 467–76.
  12. Kittler, H., Seltenheim, M., Dawid, M., et al., 2000b, Frequency and characteristics of enlarging common melanocytic nevi. Arch Dermatol, 136, 316–20.
  13. Menzies, S.W., Gutenev, A., Avramidis, M., Batrac, A. & McCarthy, W.H., 2001, Short-term digital surface microscopic monitoring of atypical or changing mela- nocytic lesions. Arch Dermatol, 137, 1583–9.
  14. Robinson, J. & Nickoloff, B., 2004, Digital epiluminescence microscopy monitoring of high-risk patients. Arch Dermatol, 140, 49–56.
  15. Zalaudek, I., Karin, S., Marghoob, A., et al., 2011, Frequency of dermoscopic nevus subtypes by age and body site: a Cross-sectional Study. Arch Dermatol, 147, 663–70.